Article Versions Notes

Turkez H, Cacciatore I, Marinelli L, Fornasari E, Aslan ME, Cadirci K, Kahraman CY, Caglar O, Tatar A, Di Biase G, et al. Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease. Biomolecules. 2021; 11(1):126. https://doi.org/10.3390/biom11010126

Turkez, Hasan, Ivana Cacciatore, Lisa Marinelli, Erika Fornasari, Mehmet Enes Aslan, Kenan Cadirci, Cigdem Yuce Kahraman, Ozge Caglar, Abdulgani Tatar, Giuseppe Di Biase, and et al. 2021. "Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease" Biomolecules 11, no. 1: 126. https://doi.org/10.3390/biom11010126

Turkez, H., Cacciatore, I., Marinelli, L., Fornasari, E., Aslan, M. E., Cadirci, K., Kahraman, C. Y., Caglar, O., Tatar, A., Di Biase, G., Hacimuftuoglu, A., Di Stefano, A., & Mardinoglu, A. (2021). Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease. Biomolecules, 11(1), 126. https://doi.org/10.3390/biom11010126